Huge Gender Disparity in Cancer Research Funding in U.K.

Men received both more and larger grants than women did, ending up with three times as much funding on average.

Written byShawna Williams
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

large stack of coins with male figure, small stack of coins with female figureISTOCK, TSVIBRAVBetween 2000 and 2013, women received just 31 percent of the number of cancer research grants awarded in the U.K., and 22 percent of the total funds to investigate cancer, according to an analysis published Tuesday (May 14) in BMJ Open. “We would strongly urge policy-makers, funders and the academic and scientific community to investigate the factors leading to our observed differences and seek to ensure that women are appropriately supported in scientific endeavour,” the authors write in the paper.

The analysis examined data on both public and philanthropic grants given to support cancer research in the U.K. Male PIs were awarded 69 percent of the grants, and their grants were on average 1.3 times as large as those given to women, so that they received 78 percent of the total money allocated.

“The significant concern following such an apparent gender imbalance is the possibility of bias or inequality against women researchers, which must be addressed,” coauthor Mahiben Maruthappu tells Medscape Medical News.

Gender disparities in the sciences are well-established. For example, female PhD students tend to publish less than their male counterparts and women are less likely to have opportunities to speak at conferences or to be successful when applying for patents. The authors ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Shawna was an editor at The Scientist from 2017 through 2022. She holds a bachelor’s degree in biochemistry from Colorado College and a graduate certificate in science communication from the University of California, Santa Cruz. Previously, she worked as a freelance editor and writer, and in the communications offices of several academic research institutions. As news director, Shawna assigned and edited news, opinion, and in-depth feature articles for the website on all aspects of the life sciences. She is based in central Washington State, and is a member of the Northwest Science Writers Association and the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies